Published in Blood Weekly, December 24th, 2009
"MSI screening was performed in 275 ID-RL MSI ID-RL, were further analyzed for MMR gene expression and for BRAF/KRAS mutations since these genes are frequently altered fit MSI cancers. We also assessed the expression of O-methylguanine-DNA methyltransferase(MGMT), an enzyme whose inactivation has...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.